Explore evidence

133 cases133 out of 507 mothers living with HIV had ever undergone cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2026BMC public healthPubMeddocument of 8 observations

69.8 %HPV-specific DNA was detected in 44 of the 58 PCR-positive samples, resulting in a cervical HPV prevalence of 69.8% among 63 archived cervical cancer tissue blocks from Maiduguri, Nigeria, collected during 2013–2015.

Nigeriacancer du col de l'utérusobserved 2013-2015published 2019The Pan African medical journalPubMeddocument of 4 observations

10.8 %Cervical cancer screening prevalence among women aged 30–49 years in Nigeria was 10.8% in the South West region.

Nigeriacancer du col de l'utérusobserved 2023–24PubMeddocument of 3 observations

96.8 %96.8% of women in urban slums of Lagos, Nigeria had not heard about cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 13 observations

Cervical cancer is the second leading cause of cancer morbidity and mortality among Nigerian women.

Nigeriacancer du col de l'utéruspublished 2023African journal of reproductive healthPubMeddocument of 4 observations

0 %Uptake of pap smear was 0.0% in the intervention group at baseline.

Nigeriacancer du col de l'utéruspublished 2022BMC women's healthPubMeddocument of 5 observations

63.5 %63.5% of the participants showed good knowledge of cervical cancer screening and vaccination.

Nigeriacancer du col de l'utéruspublished 2023BMC women's healthPubMeddocument of 7 observations

44 %44% of suspected cervical cancer cases in Nigeria were referred for advanced care.

Nigeriacancer du col de l'utérusAfrica CDCdocument of 52 observations

36.7 %The level of awareness of cervical cancer screening methods among the respondents was 36.7%.

Nigeriacancer du col de l'utérusobserved 2017published 2022The Pan African medical journalPubMeddocument of 7 observations

66 casesAmong 168 pregnant women in Otukpo metropolis, 66 (39.3%) had good knowledge of HPV infection, cervical cancer and vaccination.

Nigeriacancer du col de l'utérus · human papilloma viruspublished 2024Ethiopian journal of health sciencesPubMeddocument of 7 observations

43 %Among the cancers recorded by the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018, 43% of cervical cancer cases (n = 146) were identified through health check-ups.

Nigeriacancer du col de l'utérusobserved 2016 to 2018published 2025Cancer causes & control : CCCPubMeddocument of 9 observations

46 %46% of the participants had a positive attitude towards cervical cancer screening and vaccination.

Nigeriacancer du col de l'utéruspublished 2023BMC women's healthPubMeddocument of 7 observations

80 %Among cervical cancer cases recorded by the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018, 80% of those detected via health check-ups were assigned to palliative care compared to 59% of those detected clinically.

Nigeriacancer du col de l'utérusobserved 2016 to 2018published 2025Cancer causes & control : CCCPubMeddocument of 9 observations

73.7 %Using a cut-off value of 0.45, the negative predictive value of squamous cell carcinoma antigen was 73.7%.

Nigeriacancer du col de l'utéruspublished 2025European journal of medical researchPubMeddocument of 8 observations

13.9 %13.9% of the 231 women had basic information on the prevention of cervical cancer.

Nigeriacancer du col de l'utéruspublished 2021Cancer treatment and research communicationsPubMeddocument of 11 observations

95 casesAmong 168 pregnant women in Otukpo metropolis, 95 (56.6%) demonstrated positive attitude towards HPV infection, cervical cancer and vaccination.

Nigeriacancer du col de l'utérus · human papilloma viruspublished 2024Ethiopian journal of health sciencesPubMeddocument of 7 observations

91.2 %91.2% of respondents were not aware of cervical cancer screening.

Nigeriacancer du col de l'utéruspublished 2021JCO global oncologyPubMeddocument of 7 observations

16 pointsThe health education intervention yielded a net gain of 16.0 points in attitude toward cervical cancer screening among adult women in Cross River State, Nigeria.

Nigeriacancer du col de l'utéruspublished 2023African journal of reproductive healthPubMeddocument of 4 observations

7 %Post-intervention, knowledge of cervical cancer symptoms increased from 7.0% to 12.0% in the control group.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 12 observations

41.7 %The primary case finder screening positive predictive value was 41.7% using gynaecologist review as confirmatory test.

Nigeriacancer du col de l'utérusobserved October 2020 to July 2021published 2023Reproductive healthPubMeddocument of 9 observations

59.5 %Post-intervention, risk factor knowledge improved to 59.5% in the intervention group.

Nigeriacancer du col de l'utéruspublished 2022West African journal of medicinePubMeddocument of 12 observations

9.1 %9.1% of respondents had heard of HPV vaccination as a preventive measure for cervical cancer in a community health outreach program in Ituku, Enugu State, Nigeria.

Nigeriacancer du col de l'utérusobserved 2024published 2026Rural and remote healthPubMeddocument of 8 observations

33.3 %Of the 13,518 women living with HIV eligible for cervical cancer screening, only 4,499 (33.3%) were screened.

Nigeriacancer du col de l'utérusobserved March to August 2023published 2026BMC health services researchPubMeddocument of 5 observations

84.5 %More than half of the respondents had good cervical cancer practices (84.5%).

Nigeriacancer du col de l'utérusobserved April 2021published 2024The Pan African medical journalPubMeddocument of 8 observations

26.8 %26.8% of rural women in North Central Nigeria had fair/good knowledge of cervical cancer signs and symptoms.

Nigeriacancer du col de l'utéruspublished 2026Rural and remote healthPubMeddocument of 21 observations